ifosfamide has been researched along with resorufin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harimoto, N; Hashimoto, I; Ijima, H; Kawabata, K; Kawakami, K; Mu, C; Sakai, S; Salmons, B; Tanaka, S | 1 |
Düvier, D; Gregor, W; Günzburg, WH; Holzmüller, H; Lengler, J; Omann, M; Renner, M; Salmons, B | 1 |
2 other study(ies) available for ifosfamide and resorufin
Article | Year |
---|---|
Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biophysics; Cats; Cell Line; Cell Size; Cell Survival; Cytochrome P-450 CYP2B1; Drug Delivery Systems; Humans; Ifosfamide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Oxazines; Particle Size; Sepharose; Temperature; Time Factors | 2005 |
Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Survival; Cytochrome c Group; Cytochrome P-450 CYP2B1; Dose-Response Relationship, Drug; Genetic Therapy; Humans; Ifosfamide; Mice; NADPH-Ferrihemoprotein Reductase; NIH 3T3 Cells; Oxazines; Plasmids; Prodrugs; Transfection | 2006 |